🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10178+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10178 recruiting trials

Phase 1, PHASE2RecruitingNCT07150806

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

👨‍⚕️ Joshua D Palmer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT06964815

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

🏥 Istituto Oncologico Veneto IRCCS📍 16 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07156565

Actinium Therapy for Late-stage Aggressive Sarcomas

🏥 Ratio Therapeutics, Inc.📍 6 sites📅 Started Nov 2025View details ↗
NARecruitingNCT07500883

Basic Body Awareness Therapy Added to Scoliosis-Specific Exercise in Adolescents With Scoliosis

👨‍⚕️ Gözde Yağcı, Prof. Dr., Hacettepe University📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT06478121

Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)

👨‍⚕️ Andrew Hattersley, FRS, FMed, University of Exeter📍 1 site📅 Started Nov 2025View details ↗
EARLY_Phase 1RecruitingNCT07239895

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

🏥 Regend Therapeutics📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07232420

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors

🏥 Sichuan Baili Pharmaceutical Co., Ltd.📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07125872

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

🏥 ImmunityBio, Inc.📍 2 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06895486

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

👨‍⚕️ Xavier Saez Llorens, MD, Cevaxin📍 3 sites📅 Started Nov 2025View details ↗
NARecruitingNCT07300332

Exercise Training and Vitamin D Metabolism

👨‍⚕️ Dimitrios Draganidis, PhD, University of Thessaly📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07085338

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

👨‍⚕️ Sara Federico, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07240610

Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma

👨‍⚕️ Hiroshi Onishi, MD, PhD, University of Yamanashi📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT06983821

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

👨‍⚕️ David Massicotte-Azarniouch, MD, MSc, The Ottawa Hospital📍 2 sites📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07112378

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 6 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07228364

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

🏥 AstraZeneca📍 15 sites📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07168161

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

👨‍⚕️ Minghui Zhao, M.D., Peking University First Hospital📍 50 sites📅 Started Nov 2025View details ↗
RecruitingNCT07414056

Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation

🏥 Ain Shams University📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07228793

Natural History Study of Patients With EYS-Associated RP

👨‍⚕️ Marianna Weener, MD, PhD, Oftalmic📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07428356

Histotripsy for Ablation of Liver Tumours in Asia

👨‍⚕️ Prof Brian Goh, MBBS, MMed, MSc, FRCSEd, FAMS, National Cancer Centre, Singapore📍 3 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07110844

Teclistamab-Daratumumab in AL Amyloidosis

👨‍⚕️ Suzanne Lentzsch, MD, PhD, Columbia University📍 1 site📅 Started Nov 2025View details ↗
← PreviousPage 46 of 509Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →